On-Q-ity Adds $5M to Series A Financing Round | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer diagnostics startup On-Q-ity said yesterday that it has received a $5 million investment from Atlas Ventures, bringing its total Series A financing funding to $26 million.

In November, On-Q-ity closed the first $21 million Series A financing round, which was led by MDV-Mohr Davidow Ventures. Bessemer Venture Partners, Physic Ventures, and Northgate Capital also participated in the financing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.